Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer is a research paper published in Therapeutic Advances in Medical Oncology (2022). On theSindex it has a DataRank of 0.672. It has been cited 15 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.256
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
Genentech
Grant: 9617179
fundación científica asociación española contra el cáncer
Grant: PAO16174042
National Cancer Institute
Grant: P50 CA168504
National Health and Medical Research Council of Australia
Grant: GNT1177357
National Institutes of Health
Grant: 1U54CA225088
Ayudas Para la Movilidad del Personal Investigador
Grant: M-BAE; BA18/00044
susan g. komen for the cure
Grant: CCR18547966
National Institutes of Health
Grant: 5P50CA168504-03
Overcoming Resistance to Standard HER2-Directed Therapies for Breast Cancer
National Institutes of Health
Grant: 5U54CA225088-05
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
FWCI
1.01
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
sj-docx-1-tam-10.1177_17588359221113269 – Supplemental material for Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
sj-docx-1-tam-10.1177_17588359221113269 – Supplemental material for Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer